This course was presented in person at World Sleep 2025 in Singapore.

To access the session recording, navigate to the content tab and click the view video button. 

Session Schedule

Find a specific presentation in the course by navigating to the timestamp indicated below.

0:00:00
Introduction
Joshua Gooley (Singapore)

0:19:00
The circadian timing system
Joshua Gooley (Singapore)

0:59:30
Effects of light on the circadian timing system
Christian Cajochen (Switzerland)

1:39:50
Discussion / Question and answer

2:02:00
Methods for measuring and monitoring circadian rhythms
Andrew Phillips (Australia)

2:37:20
The circadian clock and health
Shantha Rajaratnam (Australia)

3:16:50
Discussion / Question and answer

3:40:30
Circadian regulation of cardiometabolic health
Frank A.J.L. Scheer (United States)

4:21:25
The circadian clock in ageing and neurodegenerative disease
Aleks Videnovic (United States)

5:07:45
Discussion / Question and answer

5:21:00
Circadian rhythm sleep-wake phase disorders
Sabra Abbott (United States)

Recording not available: Circadian strategies for occupational health and safety
Diane Boivin (Canada)

5:55:50
Course wrap-up & practice points

This course was presented in person at World Sleep 2025 in Singapore.

To access the session recording, navigate to the content tab and click the view video button. 

Session Schedule

Find a specific presentation in the course by navigating to the timestamp indicated below.

0:00:00
Sleep, sleep loss, and cognition
Michael Chee (Singapore)

0:54:45
Sleep neuroscience
John Peever (Canada)

1:44:45
Sleep and health disparities
Michael Grandner (United States)

2:35:00
Sleep and circadian rhythms
Christian Cajochen (Switzerland)

3:16:30
Sleep and aging
Tamar Shochat (Israel)

4:07:00
Latest trends in wearable sleep technology
Hannah Scott (Australia)

4:49:45
Sleep-disordered breathing
Winifred Randerath (Germany)

5:36:00
Insomnia and mental health
Laura Palagini (Italy)

This course was presented in person at World Sleep 2025 in Singapore.

To access the session recording, navigate to the content tab and click the view video button. 

Session Schedule

Find a specific presentation in the course by navigating to the timestamp indicated below.

0:00:00
Introduction
Amir Sharafkhaneh (United States)

0:14:45
Mastering machine learning (ML): The future of sleep data analysis
Javad Razjouyan (United States)

0:56:30
Generative AI and LLM:
Shirin Shafazand (United States)

1:43:45
Deep learning decoded: Elevating sleep analysis to the next level
Henri Korkalainen (Finland)

2:25:15
Big data, bigger impact: Transforming sleep research with AI
Ju Lynn Ong (Singapore)

3:12:00
AI in action: Revolutionizing the diagnosis of sleep disorders
Sulaiman S. Alsaif (Saudi Arabia)

3:47:00
Personalized sleep medicine: AI-powered treatment strategies
Amir Sharafkhaneh (United States)

4:36:15
Next-gen sleep monitoring: AI and wearable technology
Thomas Penzel (Germany)

5:21:15
AI's role in scientific writing and peer-review: Balancing benefits and risks
Ahmed BaHammam (Saudi Arabia)

6:09:00
Limitations, legal aspects and dangers of AI use
Haitham Jahrami (Bahrain)

6:25:45
Question and answer

Course Summary:

Artificial intelligence (AI) represents a valuable new tool for sleep research and sleep medicine.  AI can enhance sleep disorders detection, differential diagnosis, treatment, and prognosis. In this manner, AI potentially promises individualized care.

This course will review AI’s techniques, limitations, implementation, and its socio-legal complexities.  Course participants will acquire a better understanding of AI and its applications.  AI can assist forward-thinking clinicians, researchers, and healthcare professionals in their respective fields.

Experts will explain “how” and “where: of AI applications in sleep medicine. The course is divided into two modules: the first will attempt to demystify AI technology, providing attendees with the technical basics needed to understand and how to apply AI tools. The second will illustrate several clinical applications related to sleep disorders’ diagnostics, therapeutics, and patient care.

Whether you're a clinician looking to enhance your practice with AI-driven tools, a researcher aiming to innovate in the field and/or simply curious about the future of sleep medicine, this course will serve your interests. It will hopefully also empower you to participate in what way become technology’s next big thing.

Learning objectives:

Upon completion of this activity, participants will be able to:
• Explain machine learning, its applications, and its pitfalls as it relates to sleep medicine
• Explore what LLM and generative AI are, investigate their applications, and evaluate their shortcomings as they relate to sleep medicine
• Examine the concept of deep learning, its applications in sleep analysis, and its pitfalls related to sleep medicine
• Analyze big data, its uses, and potential shortcomings in the field of sleep medicine
• Identify examples of AI use in advancing the diagnosis of sleep disorders and evaluate the future of AI in the diagnosis of sleep disorders
• Describe examples of AI use in the treatment of sleep disorders and assess the future of AI in initiation and follow-up of sleep disorders’ therapy
• Review wearable technology, its applications, and shortcomings as they relate to sleep medicine
Evaluate the value of AI in scientific writing and peer review, including its strengths, weaknesses, and legal implications
Discuss legal aspects and shortfalls of the use of AI in healthcare, with a specific focus on sleep medicine

This course was presented in person at World Sleep 2025 in Singapore.

To access the session recording, navigate to the content tab and click the view video button. 

Session Schedule

0:00:00
Introduction
Atul Malhotra (United States)

0:13:00
Global trend in obstructive sleep apnea diagnosis
Mary Ip (Hong Kong)

0:57:30
Health consequences in obstructive sleep apnea
Kristina Kairaitis (Australia)

1:31:00
Question and answer

1:48:00
Positive airway pressure therapy in OSA
Naricha Chirakalwasan (Thailand)

2:28:15
Non-positive airway pressure therapy in OSA
Atul Malhotra (United States)

3:03:15
Question and answer

Course Summary:

Obstructive sleep apnea (OSA) is a highly prevalent disorder. Understanding current epidemiological data is crucial for recognizing the scale of the condition and tailoring interventions. Diagnostic tools, such as polysomnography, home sleep apnea testing (HSAT), and wearable technologies, have improved the identification of OSA, though barriers to diagnosis persist in low-resource settings. Untreated OSA has profound short- and long-term health consequences, including increased risks of cardiovascular and metabolic diseases, as well as cognitive and psychological impairments that degrade quality of life. Current treatment modalities can be divided into positive airway pressure (PAP) therapy and non-PAP therapy. Various PAP modalities, such as CPAP, BPAP, and ASV, accommodate different patient needs, and addressing adherence barriers is vital for successful treatment and enhance treatment efficacy. Beyond PAP therapy, alternative treatments such as oral appliances, positional therapy, weight management, and surgical interventions offer personalized therapy based on patient-specific factors. In summary, after participating in this educational course, the audience will acquire the updated knowledge from comprehensive evidence-based review on diagnosis and management strategies for OSA from global perspectives.

Learning Objectives:

Upon completion of this CME activity, participants will be able to:

· Identify current epidemiological data of OSA and describe the global prevalence of OSA and its variations across different regions, populations, and socioeconomic groups.
· Identify current and emerging diagnostic tools and techniques, including advancements in polysomnography, home sleep apnea testing (HSAT), and wearable technologies
· Compare international guidelines and practices for OSA diagnosis
· Address barriers to diagnose OSA in low-resource settings
· Understand the association between OSA and cancer prevalence
· Identify the impact of OSA on atherosclerosis
· Explore the relationship between OSA and ocular conditions
· Evaluate clinical strategies for managing OSA to mitigate vascular risks
· Identify the types of PAP therapy: differentiate between the various modalities of PAP therapy, including CPAP, APAP, BPAP, AutoBPAP, BPAP-VT, ASV, and their indications
· Implement the modalities to address common barriers to PAP adherence and strategies to improve compliance
· Able to interpret downloaded PAP data and troubleshooting the problems
· Describe alternative treatment to PAP therapy including oral appliances, positional therapy, weight management including the emerging data on GLP-1 receptor agonist, and surgical interventions
· Understand the indications, benefits, and limitations of non-PAP therapy in the management of OSA based on current evidence
· Implement the knowledge to develop treatment strategy for personalized therapy for OSA

This course was presented in person at World Sleep 2025 in Singapore.

To access the session recording, navigate to the content tab and click the view video button. 

Session Schedule

Find a specific presentation in the course by navigating to the timestamp indicated below.

0:00:00
Introduction
C.M. Yang (Taiwan)

0:08:30
Theoretical foundation, assessment, and conceptualization for CBT-I
C.M. Yang (Taiwan)

0:54:15
Core components of CBT-I and treatment planning
Bei Bei (Australia)

1:45:45
Question and answer

2:00:00
Managing arousal, sleep reactivity, and integrating mindfulness in CBT-I
Philip Cheng (United States)

2:48:15
Behavioral sleep medicine in medical and special populations: Tailoring existing approaches for diverse needs
Ariel Neikrug (United States)

3:29:00
Question and answer

Course Summary:

This course will provide an overview of the theories and practice of cognitive and behavioral approaches to treating insomnia. The audience will learn the evidence and basic applications of Cognitive Behavioural Therapy for Insomnia (CBT-I) in the first half of the course. In the second half of the course, core components of CBT-I will be expanded to address hyperarousal and sleep reactivity with discussions of integration of mindfulness, and how components of CBT-I can be tailored in medical and special populations. The course will finish with a panel discussion and Q&A with the audience.

Learning Objectives:

Upon completion of this CME activity, participants will be able to:
• Understand the theoretical foundations of Cognitive Behavioral Therapy for Insomnia (CBT-I), including assessment and conceptualization strategies
• Identify the core components of CBT-I for developing treatment plans for individuals with insomnia
• Identify ways to integrate mindfulness to manage arousal and sleep reactivity in CBT-I
• Adapt and tailor cognitive and behavioral techniques for use in medical and special populations

This course was presented in person at World Sleep 2025 in Singapore.

To access the session recording, navigate to the content tab and click the view video button. 

Session Schedule

Find a specific presentation in the course by navigating to the timestamp indicated below.

0:00:00
Pediatric sleep disordered breathing: Emerging issues
Kate Chan (Hong Kong)

0:37:45
Sleep problems from infancy to middle childhood: Is there a skeleton key treatment for all
Michael Gradisar (Sweden)

1:10:15
Psychopharmacology in sleepless children with neurodevelopmental disorders: When, which, how?
Paul Gringras (United Kingdom)

1:47:00
Discussion / Question and answer

2:12:25
The sleepy child: Hypersomnolence in childhood
Kiran Maski (United States)

2:49:30
The 4C model of healthy sleep for trauma-exposed children
Candice Alfano (United States)

3:29:15
Question and answer

Course Summary:

Join leading experts in pediatric sleep medicine for a state-of-the-art course covering the latest advances and challenges in managing sleep disorders across childhood. This comprehensive program, chaired by Prof. Rosemary Horne and Dr. Michal Kahn at World Sleep Singapore 2025, brings together international specialists to address critical areas in pediatric sleep medicine. The course will explore emerging issues in pediatric sleep-disordered breathing, evidence-based behavioral interventions for sleep problems from infancy through middle childhood, and specialized approaches for managing sleep in children with neurodevelopmental disorders. Participants will also gain insights into the diagnosis and management of pediatric hypersomnolence disorders and learn about an innovative model for addressing sleep disturbances in trauma-exposed children.
Through case-based discussions, evidence-based guidelines, and practical clinical applications, this course will equip sleep researchers, sleep scientists and healthcare professionals with updated knowledge and tools to better diagnose, treat, and manage various sleep disorders in the pediatric population. Participants will learn about the latest diagnostic and therapeutic strategies, understand the developmental considerations in treating childhood sleep problems, and gain practical knowledge about psychopharmacological approaches for complex cases.

Learning objective:

Upon completion of this activity, participants will be able to:
· Evaluate diagnostic and therapeutic strategies, as well as recent advances in pediatric sleep-disordered breathing
· Recognize the key etiological factors contributing to sleep problems across the early years of development (infancy to middle-childhood)
· Apply the principles of a behavioral intervention that can be used across the early phase of the human lifespan and adapt it to the developmental stage of the child
· Recognize the importance of applying theory and empirical evidence to clinical practice
· Analyze the evidence base for a range of different medications used to manage sleep problems in children with neurodevelopmental disorders
· Determine when, and if sleep medication is indicated, which outcome measure, and which medications to use
· Recognize common signs and symptoms of excessive daytime sleepiness in children and unique features of pediatric narcolepsy
· Identify various causes of hypersomnolence in children, including central disorders of hypersomnolence, medical conditions, and lifestyle factors
· Recognize the pervasiveness of sleep disturbances among children exposed to trauma and become familiar with a concise model for addressing these problems in various settings

This course was presented in person at World Sleep 2025 in Singapore.

To access the session recording, navigate to the content tab and click the view video button. 

Session Schedule

Find a specific presentation in the course by navigating to the timestamp indicated below.

0:00:00
Introduction

0:02:00
State of the art on OSA endotyping/precision medicine and translation potential
Danny Eckert (Australia)

0:46:15
New and emerging OSA diagnostics including multi-night monitoring
Ching Li Chai-Coetzer (Australia)

1:24:30
Sleep tracking and monitoring
Cathy Goldstein (United States)

2:09:30
Novel approaches to identify and manage downstream consequences of OSA
Robert Thomas (United States)

2:45:30
New management pathways for CPAP follow-up including digital medicine and multimodal monitoring
Jean-Louis Pépin (France)

3:21:05
Question and answer

This course was presented in person at World Sleep 2025 in Singapore.

To access the session recording, navigate to the content tab and click the view video button. 

Session Schedule

Find a specific presentation in the course by navigating to the timestamp indicated below.

0:00:00
Introduction

0:02:10
Insomnia pharmacotherapy in adults
David Neubauer (United States)

1:00:05
Insomnia pharmacotherapy in children and adolescents
Judith Owens (United States)

1:44:00
Question and answer

2:01:50
Hypnotics polypharmacy: Its risk factor and management
Yuichi Inoue (Japan)

2:34:15
Advantages and disadvantages of combining CBT-I with sleep-promoting medications
Yun Kwok Wing (Hong Kong)

3:17:00
Question and answer

Course Summary:

The use of medications in the treatment of insomnia remains an important therapeutic option. As more compounds and formulations have become available there now are greater opportunities for personalizing care for patients based on their symptoms and circumstances, as well as medication pharmacologic properties. This course will review the key features of approved insomnia disorder medications as well as commonly prescribed “off-label” medications, over-the-counter sleep aid products, and dietary supplements, such as melatonin. Separate lectures will focus on pharmacologic approaches in adults (Dr. Neubauer) and in children and adolescents (Dr. Owens). The development and clinical significance of hypnotic medication polypharmacy will be discussed by Dr. Inoue. Finally, Dr. Wing will provide an up-to-date review of combining insomnia pharmacotherapy with CBT-I.

Learning Objectives:

Upon completion of this CME activity, participants will be able to:
• Compare and contrast medications indicated for the treatment of insomnia disorder in children, adolescents, and adults
• Review the use of off-label medications, over-the-counter sleep aids, and dietary supplements for treating insomnia in children, adolescents, and adults
• Discuss key factors that contribute to personalized care in the pharmacologic management of insomnia
• Review the development, clinical significance, and resolution of hypnotic polypharmacy

This course was presented in person at World Sleep 2025 in Singapore.

To access the session recording, navigate to the content tab and click the view video button. 

Session Schedule

Find a specific presentation in the course by navigating to the timestamp indicated below.

0:00:00
Introduction

0:03:00
Sleep and cognitive function in adolescents
Michael Chee (Singapore)

0:45:35
Transitioning care 1
Narong Simakajornboon (United States)

1:06:30
Transitioning care 2 (OSA)
Albert Li (China)

1:25:00
Adolescent sleep health in developing nations 1
Ravi Gupta (India)

1:43:20
Adolescent sleep health in developing nations 2
Morenikeji Komolafe (Nigeria)

1:56:40
Question and answer

2:04:35
Measuring sleep in adolescents
Karen Spruyt (France)

2:26:45
Challenging insomnia cases 1
Guanghai Wang (China)

2:49:33
Challenging insomnia cases 2: Complex neurological conditions
Leticia Solter (Brazil)

3:05:45
Social media and sleep
Rachel Chan (Hong Kong)

3:28:00
Question and answer

Course Summary:

This advanced course offers a multidisciplinary exploration of adolescent sleep, combining cutting-edge research with real-world clinical insights. The course presents recent findings on how sleep loss affects attention, learning, and decision-making in teens, drawing on neuroimaging and behavioral studies to highlight their heightened vulnerability. It addresses the challenges of transitioning adolescents with chronic sleep disorders such as those with Down syndrome into adult care, emphasizing individualized, developmentally appropriate approaches. Sessions also spotlight sleep health disparities in low- and middle-income countries, with focused discussions on India and Nigeria, examining how social, cultural, and structural factors shape adolescent sleep and identifying low-cost, culturally sensitive interventions.

Participants will gain practical skills in measuring adolescent sleep using both clinical tools and wearable technologies, and develop strategies for managing complex insomnia cases, including those complicated by neurological conditions. The course uses case-based discussions, interactive Q&A sessions, and expert-led lectures to equip clinicians and researchers with actionable knowledge. Topics also include the impact of digital media on sleep, with evidence-based guidance for addressing screen use, circadian disruption, and related psychological factors. Designed for professionals working across global contexts, this course fosters a deeper, more nuanced understanding of adolescent sleep health and empowers attendees to implement effective, context-aware interventions.

Learning Objectives:

Upon completion of this CME activity, participants will be able to:
• Examine the neurobiological underpinnings of sleep-related cognitive changes during adolescence
• Explore models of care that support continuity and engagement during the transition from pediatric to adult care
• Analyze the progression and trajectory of obstructive sleep apnea (OSA) in individuals with Down syndrome, identifying key factors influencing its development and management
• Identify unique cultural, environmental, and systemic factors impacting adolescent sleep in developing countries
• Evaluate the influence of socioeconomic conditions and health system factors on adolescent sleep patterns in sub-Saharan Africa, identifying key challenges and opportunities for intervention
• Review objective and subjective tools for assessing sleep in adolescents
• Apply diagnostic reasoning and management strategies to real-world cases
• Evaluate and manage complex insomnia cases, including those involving comorbid neurological or developmental conditions
• Explore the effects of screen time and social media use on adolescent sleep

This course was presented in person at World Sleep 2025 in Singapore.

To access the session recording, navigate to the content tab and click the view video button. 

Session Schedule

Find a specific presentation in the course by navigating to the timestamp indicated below.

0:00:00
Introduction
Morenikeji Komolafe (Nigeria)
Fang Han (China)

0:17:40
Overview of hypersomnia
Kingman Strohl (United States)

0:57:40
New Insights in narcolepsy research
Emmanuel Mignot (United States)

1:41:30
Question and answer

1:54:00
Recognition of narcolepsy in children
Yu Shu Huang (Taiwan)

2:26:15
Progress in medical treatment of narcolepsy and other hypersomnia of central origin
Yves Dauvilliers (France)

3:17:30
Question and answer

3:42:05
Narcolepsy and metabolism: What do we know?
Ahmed BaHammam (Saudi Arabia)

4:15:30
Comorbidity and burden of narcolepsy
S.C. Hong (Korea, Republic of)

4:32:55
Diagnostic burden and challenges of idiopathic hypersomnia
Lucie Barateau (France)

4:55:25
Question and answer

5:01:15
Challenges in diagnosing and managing narcolepsy in other regions of the world: Africa
Morenikeji Komolafe (Nigeria)

5:29:05
From isolation to international narcolepsy awareness: The power of peers and role models to build a global movement
Julie Flygare (United States)

6:01:45
A parent’s journey: From narcolepsy diagnosis to shaping the future of sleep research
Lindsay Jesteadt (United States)

6:21:05
Question and answer